Find therapies in clinical trials near you

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Spironolactone with drug combination to improve health in adults with Fontan circulation (clinical trial)

Spironolactone with drug combination to improve health in adults with Fontan circulation (clinical trial)

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function

Randomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Sodium-glucose cotransporter-2 inhibitor drug combination for patients with diabetes and heart attack to slow coronary artery disease progression

Sodium-glucose cotransporter-2 inhibitor drug combination for patients with diabetes and heart attack to slow coronary artery disease progression

Study of dapagliflozin and semaglutide to reverse prediabetes to normal blood sugar levels in patients with coronary artery disease

Study of dapagliflozin and semaglutide to reverse prediabetes to normal blood sugar levels in patients with coronary artery disease

A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease

Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease

Study of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure

Study of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure